Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/10994
Título
Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy.
Autor(es)
Font, Albert | Domènech, Montserrat | Benítez, Raquel | Rava, Marta CNIO | Marqués, Miriam | Ramírez, Jose L | Pineda, Silvia CNIO | Domínguez-Rodríguez, Sara | Gago, José L | Badal, Josep | Carrato, Cristina | López, Héctor | Quer, Ariadna | Castellano, Daniel | Malats, Nuria CNIO | Real Arribas, Francisco CNIO
Fecha de publicación
2020-07-03
Cita
Cancers (Basel). 2020;12(7):1784
Idioma
Inglés
Tipo de documento
journal article
Resumen
Platinum-based neoadjuvant chemotherapy (NAC) increases the survival of patients with organ-confined urothelial bladder cancer (UBC). In retrospective studies, patients with basal/squamous (BASQ)-like tumors present with more advanced disease and have worse prognosis. Transcriptomics-defined tumor subtypes are associated with response to NAC.
To investigate whether immunohistochemical (IHC) subtyping predicts NAC response.
Patients with muscle-invasive UBC having received platinum-based NAC were identified. Tissue microarrays were used to type tumors for KRT5/6, KRT14, GATA3, and FOXA1.
progression-free survival and disease-specific survival; univariable and multivariate Cox regression models were applied.
We found a very high concordance between mRNA and protein expression. Using IHC-based hierarchical clustering, we classified 126 tumors in three subgroups: BASQ-like (FOXA1/GATA3 low; KRT5/6/14 high), Luminal-like (FOXA1/GATA3 high; KRT5/6/14 low), and mixed-cluster (FOXA1/GATA3 high; KRT5/6 high; KRT14 low). Applying multivariable analyses, patients with BASQ-like tumors were more likely to achieve a pathological response to NAC (OR 3.96; p = 0.017). The clinical benefit appeared reflected in the lack of significant survival differences between patients with BASQ-like and luminal tumors.
Patients with BASQ-like tumors-identified through simple and robust IHC-have a higher likelihood of undergoing a pathological complete response to NAC. Prospective validation is required.
Palabras clave
BLADDER-CANCER | Neoadjuvant chemotherapy | Mmolecular taxonomy | Immunohistochemistry | Squamous-like tumors | Basal
Versión en línea
DOI
Aparece en las colecciones
Ficheros en el ítem
- Nombre:
- Immunohistochemistry-BasedTaxo ...
- Tamaño:
- 1.049Mb
- Formato:
- Descripción:
- Artículo principal
- Nombre:
- cancers-12-01784-s001.pdf
- Tamaño:
- 902.8Kb
- Formato:
- Descripción:
- Información suplementaria